Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 179

    Article Cited by others


Prognostic factors in pancreatic cancer

Andrén-Sandberg Åke

Year : 2012| Volume: 4| Issue : 1 | Page no: 9-12

   This article has been cited by
1 Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies
Sana Raoof, Richard J. Lee, Kunal Jajoo, Joseph D. Mancias, Timothy R. Rebbeck, Steven J. Skates
Cancer Epidemiology, Biomarkers & Prevention. 2022; 31(6): 1139
[Pubmed]  [Google Scholar] [DOI]
2 P-glycoprotein associated with diabetes mellitus and survival of patients with pancreatic cancer: 8-year follow-up
Nan Hu,Hui Wang,Qing Qian,Yan Jiang,Jun Xie,Dachuan Zhang,Qing Li,Sulan Zou,Rong Chen
Brazilian Journal of Medical and Biological Research. 2020; 53(11)
[Pubmed]  [Google Scholar] [DOI]
3 The role of selected chemokines and their specific receptors in pancreatic cancer
Marta Lukaszewicz-Zajac,Mariusz Gryko,Barbara Mroczko
The International Journal of Biological Markers. 2018; 33(2): 141
[Pubmed]  [Google Scholar] [DOI]
4 Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients After Pancreaticoduodenectomy
Nicolás Macías,José M. Sayagués,Carmen Esteban,Manuel Iglesias,Luís M. González,Jose Quiñones-Sampedro,María L. Gutiérrez,Luís A. Corchete,Maria M. Abad,Oscar Bengoechea,Luís Muñoz-Bellvis
Journal of Clinical Gastroenterology. 2018; 52(2): e11
[Pubmed]  [Google Scholar] [DOI]
5 Yonsei criteria: a clinical reflection of stage I left-sided pancreatic cancer
Jae Uk Chong,Sung Hyun Kim,Ho Kyoung Hwang,Chang Moo Kang,Woo Jung Lee
Oncotarget. 2017; 8(67): 110830
[Pubmed]  [Google Scholar] [DOI]
6 The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma – A systematic review and meta-analysis
Stephan Schorn,Ihsan Ekin Demir,Bernhard Haller,Florian Scheufele,Carmen Mota Reyes,Elke Tieftrunk,Mine Sargut,Rüdiger Göß,Helmut Friess,Güralp Onur Ceyhan
Surgical Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]
7 MUC4-promoted neural invasion is mediated by the axon guidance factor netrin-1 in PDAC
Linjun Wang,Xiaofei Zhi,Yi Zhu,Qun Zhang,Weizhi Wang,Zheng Li,Jie Tang,Jiwei Wang,Song Wei,Bowen Li,Jianping Zhou,Jianguo Jiang,Li Yang,Hao Xu,Zekuan Xu
Oncotarget. 2015; 6(32): 33805
[Pubmed]  [Google Scholar] [DOI]
8 Identification of Poor-outcome Biliopancreatic Carcinoma Patients With Two-marker Signature Based on ATF6a and p-p38 “STARD Compliant”
J. Martinez-Useros,T. Georgiev-Hristov,A. Borrero-Palacios,M.J. Fernandez-Aceñero,M. Rodríguez-Remírez,L. del Puerto-Nevado,A. Cebrian,M.T. Gomez del Pulgar,A. Cazorla,R. Vega-Bravo,N. Perez,A. Celdran,J. Garcia-Foncillas
Medicine. 2015; 94(45): e1972
[Pubmed]  [Google Scholar] [DOI]
9 Prognostic factors related with survival in patients with pancreatic adenocarcinoma
Ahmet Bilici
World Journal of Gastroenterology. 2014; 20(31): 10802
[Pubmed]  [Google Scholar] [DOI]


Read this article